2-Jun-2026
No headlines found.
Inogen Announces First Quarter 2026 Financial Results
Business Wire (Thu, 7-May 4:05 PM ET)
Inogen to Report First Quarter 2026 Financial Results on May 7, 2026
Business Wire (Thu, 23-Apr 8:30 AM ET)
Inogen Announces the Appointment of Vafa Jamali to Board of Directors
Business Wire (Mon, 6-Apr 4:00 PM ET)
Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference
Business Wire (Tue, 31-Mar 8:30 AM ET)
Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire (Mon, 30-Mar 4:05 PM ET)
Inogen Announces Leadership Appointments Designed to Accelerate Next Phase of Growth
Business Wire (Mon, 30-Mar 4:00 PM ET)
Inogen Announces Participation in the KeyBanc Virtual Life Sciences & MedTech Investor Forum
Business Wire (Thu, 5-Mar 9:15 AM ET)
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
Inogen trades on the NASDAQ stock market under the symbol INGN.
As of June 2, 2026, INGN stock price was flat at $6.09 with 506,546 million shares trading.
INGN has a beta of 1.59, meaning it tends to be more sensitive to market movements. INGN has a correlation of 0.21 to the broad based SPY ETF.
INGN has a market cap of $164.88 million. This is considered a Micro Cap stock.
Last quarter Inogen reported $85 million in Revenue and -$.14 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.08.
In the last 3 years, INGN traded as high as $13.33 and as low as $4.13.
The top ETF exchange traded funds that INGN belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.
INGN has underperformed the market in the last year with a price return of -5.2% while the SPY ETF gained +30.1%. INGN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -0.2% and -3.3%, respectively, while the SPY returned +11.0% and +2.8%, respectively.
INGN support price is $5.90 and resistance is $6.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INGN shares will trade within this expected range on the day.